Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

V A Miller

Showing results (1-10 of 53) with videos related to

Pageof 6
Sort By:
Clinical Lung Cancer|January 17, 2004
Trials of vinorelbine and docetaxel in the treatment of advanced non small-cell lung cancerV A Miller
Seminars in Oncology|August 15, 1998
Docetaxel in the management of advanced non-small cell lung cancerV A Miller
Seminars in Oncology|August 1, 1997
Docetaxel (Taxotere) and vinorelbine in the treatment of advanced non-small cell lung cancer: preliminary results of a phase I/II trialV A Miller
Child: Care, Health and Development|June 11, 2010
Child and parent perceptions of monitoring in chronic illness management: a qualitative studyJ Hafetz, V A Miller
Seminars in Oncology|May 16, 2000
Docetaxel (Taxotere) as a single agent and in combination chemotherapy for the treatment of patients with advanced non-small cell lung cancerV A Miller, M G Kris
Seminars in Oncology|December 10, 1999
Phase II trials of vinorelbine and docetaxel in the treatment of advanced non-small cell lung cancerL M Krug, V A Miller
Topics in Health Care Financing|January 1, 1985
Process for integrating market strategies and financial strategiesJ W Killian, V A Miller
Urology|July 1, 1995
Primary squamous cell carcinoma of the prostate after radiation seed implantation for adenocarcinomaV A Miller, V Reuter, H I Scher
Management Focus|February 10, 1983
Fiscal fitnessW R Richards, V A Miller, T E Fitz
Seminars in Oncology|August 1, 1997
The development of docetaxel (Taxotere) in non-small cell lung cancerM G Kris, V A Miller, K K Ng, et al.
Pageof 6

Showing results (1-10 of 53) with videos related to

Sort By:
Pageof 6
Clinical Lung Cancer|January 17, 2004
Trials of vinorelbine and docetaxel in the treatment of advanced non small-cell lung cancerV A Miller
Seminars in Oncology|August 15, 1998
Docetaxel in the management of advanced non-small cell lung cancerV A Miller
Seminars in Oncology|August 1, 1997
Docetaxel (Taxotere) and vinorelbine in the treatment of advanced non-small cell lung cancer: preliminary results of a phase I/II trialV A Miller
Child: Care, Health and Development|June 11, 2010
Child and parent perceptions of monitoring in chronic illness management: a qualitative studyJ Hafetz, V A Miller
Seminars in Oncology|May 16, 2000
Docetaxel (Taxotere) as a single agent and in combination chemotherapy for the treatment of patients with advanced non-small cell lung cancerV A Miller, M G Kris
Seminars in Oncology|December 10, 1999
Phase II trials of vinorelbine and docetaxel in the treatment of advanced non-small cell lung cancerL M Krug, V A Miller
Topics in Health Care Financing|January 1, 1985
Process for integrating market strategies and financial strategiesJ W Killian, V A Miller
Urology|July 1, 1995
Primary squamous cell carcinoma of the prostate after radiation seed implantation for adenocarcinomaV A Miller, V Reuter, H I Scher
Management Focus|February 10, 1983
Fiscal fitnessW R Richards, V A Miller, T E Fitz
Seminars in Oncology|August 1, 1997
The development of docetaxel (Taxotere) in non-small cell lung cancerM G Kris, V A Miller, K K Ng, et al.
Pageof 6